ATE433439T1 - Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung - Google Patents
Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendungInfo
- Publication number
- ATE433439T1 ATE433439T1 AT03766505T AT03766505T ATE433439T1 AT E433439 T1 ATE433439 T1 AT E433439T1 AT 03766505 T AT03766505 T AT 03766505T AT 03766505 T AT03766505 T AT 03766505T AT E433439 T1 ATE433439 T1 AT E433439T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- chosen
- group
- cck
- production
- Prior art date
Links
- -1 ANTHRANYL Chemical class 0.000 title 1
- 229940107137 cholecystokinin Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002TO000674A ITTO20020674A1 (it) | 2002-07-26 | 2002-07-26 | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
| PCT/IB2003/002922 WO2004013087A1 (en) | 2002-07-26 | 2003-07-23 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE433439T1 true ATE433439T1 (de) | 2009-06-15 |
Family
ID=11459544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03766505T ATE433439T1 (de) | 2002-07-26 | 2003-07-23 | Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7294648B2 (de) |
| EP (1) | EP1532105B1 (de) |
| JP (1) | JP4530853B2 (de) |
| AT (1) | ATE433439T1 (de) |
| AU (1) | AU2003253114B8 (de) |
| CA (1) | CA2493789C (de) |
| DE (1) | DE60327932D1 (de) |
| ES (1) | ES2325496T3 (de) |
| IT (1) | ITTO20020674A1 (de) |
| PT (1) | PT1532105E (de) |
| WO (1) | WO2004013087A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7241759B2 (en) | 2003-03-28 | 2007-07-10 | Janssen Pharmaceutica N.V. | Benzo[1,2,5]thiadiazole compounds |
| EA200600203A1 (ru) | 2003-08-08 | 2006-08-25 | Янссен Фармацевтика, Н. В. | Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2 |
| JP2008514608A (ja) | 2004-09-24 | 2008-05-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルホンアミド化合物 |
-
2002
- 2002-07-26 IT IT2002TO000674A patent/ITTO20020674A1/it unknown
-
2003
- 2003-07-23 AT AT03766505T patent/ATE433439T1/de not_active IP Right Cessation
- 2003-07-23 PT PT03766505T patent/PT1532105E/pt unknown
- 2003-07-23 EP EP03766505A patent/EP1532105B1/de not_active Expired - Lifetime
- 2003-07-23 DE DE60327932T patent/DE60327932D1/de not_active Expired - Lifetime
- 2003-07-23 US US10/523,075 patent/US7294648B2/en not_active Expired - Fee Related
- 2003-07-23 JP JP2004525597A patent/JP4530853B2/ja not_active Expired - Fee Related
- 2003-07-23 AU AU2003253114A patent/AU2003253114B8/en not_active Ceased
- 2003-07-23 CA CA2493789A patent/CA2493789C/en not_active Expired - Fee Related
- 2003-07-23 ES ES03766505T patent/ES2325496T3/es not_active Expired - Lifetime
- 2003-07-23 WO PCT/IB2003/002922 patent/WO2004013087A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004013087A1 (en) | 2004-02-12 |
| JP4530853B2 (ja) | 2010-08-25 |
| AU2003253114B2 (en) | 2009-07-16 |
| DE60327932D1 (de) | 2009-07-23 |
| JP2005533866A (ja) | 2005-11-10 |
| ITTO20020674A1 (it) | 2004-01-26 |
| AU2003253114B8 (en) | 2009-08-13 |
| US7294648B2 (en) | 2007-11-13 |
| AU2003253114A1 (en) | 2004-02-23 |
| CA2493789A1 (en) | 2004-02-12 |
| EP1532105A1 (de) | 2005-05-25 |
| CA2493789C (en) | 2012-05-01 |
| ES2325496T3 (es) | 2009-09-07 |
| ITTO20020674A0 (it) | 2002-07-26 |
| US20060111304A1 (en) | 2006-05-25 |
| EP1532105B1 (de) | 2009-06-10 |
| PT1532105E (pt) | 2009-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1548008A4 (de) | Verbindung mit tgf-beta-hemmender wirkung und diese enthaltende medizinische zusammensetzung | |
| DK0628311T3 (da) | Xanthinderivater som antidepressive midler | |
| BRPI0413232B8 (pt) | composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto | |
| DK1424330T3 (da) | Aktivator for peroxisom proliferator-responsiv receptor delta | |
| AR039868A1 (es) | Inhibidores selectivos de la enzima kalikreina plasmatica | |
| EA200201056A1 (ru) | Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств | |
| SE0302487D0 (sv) | Novel compounds | |
| DK1169298T3 (da) | Farmaceutiske forbindelser | |
| ATE266664T1 (de) | Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DK1644389T3 (da) | Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger | |
| PT790248E (pt) | Derivados de 3-aza-piperidona-(tetra-hidropirimidin-2-ona) e 3-oxa-piperidona(1,3 oxazin-2-ona) sua preparacao e uso como antagonistas de taquicinina/neurocinina | |
| BRPI0210746B8 (pt) | derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação | |
| NO20001198L (no) | Pyrrolopyrrolondervater som inhibitorer av nøytrofil elastase | |
| ATE204263T1 (de) | Biologisch aktive amine | |
| TW200505446A (en) | Inhibitor of cox | |
| DE60327932D1 (de) | Anthranyl-derivate mit anti-cholecystokinin-aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung | |
| ATE265451T1 (de) | 2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| KR920012060A (ko) | 치환된 n-벤조일-n'-(2-페닐에틸)-피페라진 | |
| DE69204859D1 (de) | Substituierte Pyridinsulfonamide oder deren Salze, Verfahren zur Herstellung und diese enthaltende Herbizide. | |
| AR045600A1 (es) | Tienoimidazoles sustituidos, procedimiento para su preparacion, su uso como un medicamento o adyuvante de diagnostico y medicamento que los comprende | |
| EP1178031A4 (de) | Verfahren zur herstellung organischer verbindungen mit mangankatalysatoren oder ähnlichen verbindungen | |
| EA200300029A1 (ru) | Новые соединения карбамат и тиокарбамат подофиллотоксина, способ их получения и содержащие их фармацевтические композиции | |
| ATE195936T1 (de) | Bis-imide derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung | |
| ATE165364T1 (de) | Neue kardioaktive 17-iminomethylalkenyl-5-beta-14-beta-androstan und 17-iminoalkyl-5-beta, 14-beta- androstan derivate, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon | |
| ATE191458T1 (de) | Benzol-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |